Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.130
-0.080 (-6.61%)
Jul 20, 2026, 4:00 PM EDT - Market closed

Immuron Revenue

Immuron had revenue of 4.18M AUD in the half year ending December 31, 2025, with 77.64% growth. This brings the company's revenue in the last twelve months to 7.48M, up 14.30% year-over-year. In the fiscal year ending June 30, 2025, Immuron had annual revenue of 7.29M with 48.63% growth.

Revenue (ttm)
7.48M AUD
Revenue Growth
+14.30%
P/S Ratio
1.83
Revenue / Employee
1,068,146 AUD
Employees
7
Market Cap
9.15M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20257.29M2.38M48.63%
Jun 30, 20244.90M3.10M171.67%
Jun 30, 20231.80M1.04M135.85%
Jun 30, 2022765.19K619.42K424.91%
Jun 30, 2021145.78K-2.85M-95.13%
Jun 30, 20202.99M604.81K25.33%
Jun 30, 20192.39M544.52K29.55%
Jun 30, 20181.84M446.71K31.99%
Jun 30, 20171.40M395.12K39.47%
Jun 30, 20161.00M-1.30K-0.13%
Jun 30, 20151.00M21.33K2.17%
Jun 30, 2014981.05K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Curis7.06M
Traws Pharma2.73M
Vistagen Therapeutics1.27M
Exicure500.00K
Aprea Therapeutics123.30K
BioCardia3.00K
Revenue Rankings